Geron

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Geron and other ETFs, options, and stocks.

About GERN

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies.

CEO

Harout Semerjian

CEOHarout Semerjian

Employees

229

Employees229

Headquarters

Foster City, California

HeadquartersFoster City, California

Founded

1990

Founded1990

Employees

229

Employees229

GERN Key Statistics

Market cap

768.81M

Market cap768.81M

Price-Earnings ratio

-9.28

Price-Earnings ratio-9.28

Dividend yield

—

Dividend yield—

Average volume

8.64M

Average volume8.64M

High today

$1.25

High today$1.25

Low today

$1.19

Low today$1.19

Open price

$1.22

Open price$1.22

Volume

5.25M

Volume5.25M

52 Week high

$4.50

52 Week high$4.50

52 Week low

$1.09

52 Week low$1.09

GERN News

TipRanks 4d

Geron Announces Executive Leadership Transitions

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 4d

Geron COO Andrew Grethlein, CCO Jim Ziegler to depart

Geron (GERN) announced several executive transitions and appointments designed to align the company’s leadership structure with its strategic priorities. Andrew...

Analyst ratings

75%

of 8 ratings

Buy

75%

Hold

12.5%

Sell

12.5%

People also own

Based on the portfolios of people who own GERN. This list is generated using Robinhood data, and it’s not a recommendation.